ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 69 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $230,000 | -14.8% | 53,449 | +14.0% | 0.01% | -28.6% |
| Q4 2018 | $270,000 | -52.2% | 46,892 | -6.8% | 0.01% | -41.7% |
| Q1 2018 | $565,000 | -17.6% | 50,337 | -50.2% | 0.01% | -20.0% |
| Q4 2017 | $686,000 | +85.9% | 101,132 | +123.6% | 0.02% | +114.3% |
| Q3 2017 | $369,000 | +136.5% | 45,238 | +30.1% | 0.01% | +133.3% |
| Q2 2017 | $156,000 | – | 34,767 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 6,287,101 | $4,903,939 | 2.63% |
| Syncona Portfolio Ltd | 1,377,294 | $1,074,289 | 1.60% |
| MPM BioImpact LLC | 5,095,912 | $3,974,811 | 1.06% |
| NEA Management Company, LLC | 17,079,778 | $13,322,227 | 1.03% |
| TANG CAPITAL MANAGEMENT LLC | 5,166,954 | $4,030,224 | 0.57% |
| PFM Health Sciences, LP | 10,423,135 | $8,130,045 | 0.38% |
| Matrix Capital Management Company, LP | 38,974,185 | $30,399,864 | 0.36% |
| Long Focus Capital Management, LLC | 10,963,158 | $8,551,263 | 0.31% |
| Acuitas Investments, LLC | 479,764 | $374,216 | 0.22% |
| Endurant Capital Management LP | 311,944 | $243,316 | 0.22% |